FactSet analysts give Health Catalyst an overweight rating

Summary

According to a FactSet survey of analysts, Health Catalyst has an average rating of ‘overweight’ with an average price target of $7.45.Trading View

Impact Analysis

This event is at the company level, as it pertains specifically to Health Catalyst and the analysts’ ratings. Recent analyst actions include KeyCorp lowering its price target from $7.00 to $5.00 and maintaining an overweight rating as of April 16, Evercore ISI downgrading the stock from outperform to in line on April 9, and RBC lowering its target to $6.00 with a sector perform rating on February 27.Market Beat Additionally, Stifel Nicolaus raised its target from $5.00 to $5.50 and rated it hold on May 8, while Citigroup lowered its target from $7.00 to $6.50 with a buy rating on April 25.Market Beat These mixed ratings and target adjustments suggest varying levels of confidence among analysts, reflecting differing assessments of the company’s performance and market conditions. The primary effect is a potential fluctuation in the stock price as investors respond to these mixed signals. Investment opportunities include potential undervaluation if the average price target of $7.45 is realized, representing an upside from current market perceptions.